Saudi Pharmaceutical Industries and Medical Appliances Corporation

Informe Stock SASE:2070

Capitalización de mercado: ر.س4.2b

Salud financiera de hoja de balance de Saudi Pharmaceutical Industries and Medical Appliances

Salud financiera controles de criterios 2/6

Saudi Pharmaceutical Industries and Medical Appliances tiene unos fondos propios totales de SAR1.7B y una deuda total de SAR1.1B, lo que sitúa su ratio deuda/fondos propios en 63.5%. Sus activos y pasivos totales son SAR4.1B y SAR2.4B respectivamente. Saudi Pharmaceutical Industries and Medical Appliances El EBIT de la empresa es de SAR40.6M, por lo que su ratio de cobertura de intereses es de 0.8. Su tesorería e inversiones a corto plazo ascienden a SAR236.2M.

Información clave

66.0%

Ratio deuda-patrimonio

ر.س1.10b

Deuda

Ratio de cobertura de intereses1.6x
Efectivoر.س276.03m
Patrimonioر.س1.67b
Total pasivoر.س2.36b
Activos totalesر.س4.02b

Actualizaciones recientes sobre salud financiera

No hay actualizaciones

Recent updates

Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) Not Lagging Industry On Growth Or Pricing

Mar 21
Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) Not Lagging Industry On Growth Or Pricing

Is Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) Worth ر.س38.1 Based On Its Intrinsic Value?

Jun 26
Is Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) Worth ر.س38.1 Based On Its Intrinsic Value?

Is There An Opportunity With Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) 20% Undervaluation?

Mar 14
Is There An Opportunity With Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) 20% Undervaluation?

Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) Intrinsic Value Is Potentially 52% Above Its Share Price

Aug 02
Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) Intrinsic Value Is Potentially 52% Above Its Share Price

Saudi Pharmaceutical Industries and Medical Appliances' (TADAWUL:2070) Dividend Is Being Reduced To ر.س0.60

May 19
Saudi Pharmaceutical Industries and Medical Appliances' (TADAWUL:2070) Dividend Is Being Reduced To ر.س0.60

One Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) Analyst Just Made A Major Cut To Next Year's Estimates

May 12
One Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) Analyst Just Made A Major Cut To Next Year's Estimates

A Look At The Fair Value Of Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070)

Feb 20
A Look At The Fair Value Of Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070)

Saudi Pharmaceutical Industries and Medical Appliances' (TADAWUL:2070) Shareholders May Want To Dig Deeper Than Statutory Profit

Nov 18
Saudi Pharmaceutical Industries and Medical Appliances' (TADAWUL:2070) Shareholders May Want To Dig Deeper Than Statutory Profit

Does It Make Sense To Buy Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) For Its Yield?

Mar 30
Does It Make Sense To Buy Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) For Its Yield?

Should Saudi Pharmaceutical Industries and Medical Appliances (TADAWUL:2070) Be Disappointed With Their 50% Profit?

Feb 23
Should Saudi Pharmaceutical Industries and Medical Appliances (TADAWUL:2070) Be Disappointed With Their 50% Profit?

What You Need To Know About Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) Investor Composition

Jan 19
What You Need To Know About Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) Investor Composition

Is Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) At Risk Of Cutting Its Dividend?

Dec 16
Is Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) At Risk Of Cutting Its Dividend?

Análisis de la situación financiera

Pasivos a corto plazo: 2070Los activos a corto plazo (SAR2.2B) de la empresa superan a sus pasivos a corto plazo (SAR1.4B).

Pasivo a largo plazo: 2070Los activos a corto plazo (SAR2.2B) superan a sus pasivos a largo plazo (SAR1.0B).


Historial y análisis de deuda-patrimonio

Nivel de deuda: La relación deuda neta-capital de 2070 (49.7%) se considera alta.

Reducción de la deuda: 2070ha pasado de 32.7% a 63.5% en los últimos 5 años.

Cobertura de la deuda: 2070's debt is not well covered by operating cash flow (2.7%).

Cobertura de intereses: 2070Los pagos de intereses de su deuda no están bien cubiertos por el EBIT (0.8x cobertura).


Hoja de balance


Descubre empresas con salud financiera

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target